Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene

Molecular classification
Other (pseudogene), Not a functional protein, receptor, enzyme, transporter, or transcription factor
01

Overview

The Heterogeneous nuclear ribonucleoprotein A1 pseudogene (ENSG00000228814) is a non-coding genomic locus related to the functional HNRNPA1 gene, which encodes an RNA-binding protein involved in pre-mRNA processing and alternative splicing[3][5]. As a pseudogene, this locus does not produce a functional protein and is not considered a therapeutic target or a component of canonical molecular classifications. Numerous HNRNPA1 pseudogenes exist in the human genome, but none are known to contribute to protein function, disease, or serve as drug targets[3]. Summary of correctness: - This target is not a valid therapeutic target or physiologically relevant molecule; it represents a pseudogene arising from the duplication or retrotransposition of the active HNRNPA1 gene. - It is not a receptor, not a drug target, nor involved in well-defined biological pathways. - Any data on protein functionality, disease relevance, or druggability for HNRNPA1 does not apply to this pseudogene entry. If you need structured information about the functional HNRNPA1 protein instead, that can be provided separately.

Other names
hnRNPA1 pseudogeneHeterogeneous nuclear ribonucleoprotein A1 pseudogeneHNRNPA1P (generic pseudogene symbol)
02

Biological functions

Not applicable (pseudogenes, by definition, do not encode functional proteins, though rare regulatory functions exist in some cases. There is no evidence of such function for this locus.)
03

Disease associations

None: There is no established direct disease role for this pseudogene.Note: The protein-coding gene HNRNPA1 (not its pseudogenes) is associated with diseases like amyotrophic lateral sclerosis and cancer[3][5].
04

Biomarkers

None specific to the pseudogene

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call